Smallpox

1. Fenner F, Henderson DA, Arita I, et al. Smallpox and its eradication. Geneva: World Health Organization; 1988.Full text

2. Health and Safety Executive, Advisory Committee on Dangerous Pathogens. The approved list of biological agents. July 2021 [internet publication].Full text

3. Centers for Disease Control and Prevention. Smallpox: clinical disease. December 2016 [internet publication].Full text

4. Shchelkunov SN, Totmenin AV, Loparev VN, et al. Alastrim smallpox variola minor virus genome DNA sequences. Virology. 2000 Jan 20;266(2):361-86. Abstract

5. Isaacs SN. Working safely with vaccinia virus: laboratory technique and review of published cases of accidental laboratory infections with poxviruses. Methods Mol Biol. 2019;2023:1-27. Abstract

6. Wehrle PF, Posch J, Richter KH, et al. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull World Health Organ. 1970;43(5):669-79.Full text  Abstract

7. Sarkar JK, Mitra AC, Mukherjee MK, et al. Virus excretion in smallpox. 2. Excretion in the throats of household contacts. Bull World Health Organ. 1973 May;48(5):523-7.Full text  Abstract

8. Institute of Medicine. Assessment of future scientific needs for live variola virus. Washington, DC: National Academies Press; 1999.Full text  Abstract

9. Centers for Disease Control and Prevention. Smallpox: research. October 2021 [internet publication].Full text

10. McCarthy M. Smallpox samples are found in FDA storage room in Maryland. BMJ. 2014 Jul 10;349:g4545. Abstract

11. [No authors listed]. Smallpox in Birmingham. Br Med J. 1978 Sep 16;2(6140):837.Full text  Abstract

12. Beeching NJ, Dance DA, Miller AR, et al. Biological warfare and bioterrorism. BMJ. 2002 Feb 9;324(7333):336-9.Full text  Abstract

13. Petersen BW, Damon IK, Pertowski CA, et al. Clinical guidance for smallpox vaccine use in a postevent vaccination program. MMWR Recomm Rep. 2015 Feb 20;64(RR-02):1-26.Full text  Abstract

14. Mack TM, Thomas DB, Ali A, et al. Epidemiology of smallpox in West Pakistan. I. Acquired immunity and the distribution of disease. Am J Epidemiol. 1972 Feb;95(2):157-68. Abstract

15. Vaccination Commission. Final report of the Royal Commission appointed to inquire into the subject of vaccination. London: Her Majesty's Stationery Office; 1896.Full text

16. Pittman PR, Hahn M, Lee HS, et al. Phase 3 efficacy trial of modified vaccinia Ankara as a vaccine against smallpox. N Engl J Med. 2019 Nov 14;381(20):1897-908.Full text  Abstract

17. Stickl H, Hochstein-Mintzel V, Mayr A, et al. MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) [in German]. Dtsch Med Wochenschr. 1974 Nov 22;99(47):2386-92. Abstract

18. Mayr A, Stickl H, Müller HK, et al. The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism [in German]. Zentralbl Bakteriol B. 1978 Dec;167(5-6):375-90. Abstract

19. Centers for Disease Control and Prevention. Smallpox: contraindications to vaccination. December 2016 [internet publication].Full text

20. Badell ML, Meaney-Delman D, Tuuli MG, et al. Risks associated with smallpox vaccination in pregnancy: a systematic review and meta-analysis. Obstet Gynecol. 2015 Jun;125(6):1439-51.Full text  Abstract

21. Cono J, Casey CG, Bell DM, et al. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28.Full text  Abstract

22. UK Health Security Agency. Smallpox and vaccinia: the green book, chapter 29. September 2022 [internet publication].Full text

23. Rao AK, Petersen BW, Whitehill F, et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jun 3;71(22):734-42.Full text  Abstract

24. Centers for Disease Control and Prevention. Smallpox: prevent spread of disease. July 2017 [internet publication].Full text

25. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med. 2002 Apr 25;346(17):1300-8.Full text  Abstract

26. Dennis DT, Doberstyn EB, Awoke S, et al. Failure of cytosine arabinoside in treating smallpox: a double-blind study. Lancet. 1974 Aug 17;2(7877):377-9. Abstract

27. McKenzie PJ, Githens JH, Harwood ME, et al. Haemorrhagic smallpox. 2. Specific bleeding and coagulation studies. Bull World Health Organ. 1965;33(6):773-82.Full text  Abstract

28. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014 Jan;58(2):260-7.Full text  Abstract

29. World Health Organization. Smallpox: case definition for notification of smallpox under the IHR (2005). June 2016 [internet publication].Full text

30. Centers for Disease Control and Prevention. Smallpox/variola: 2004 case definition. April 2021 [internet publication].Full text

31. Centers for Disease Control and Prevention. Smallpox: for clinicians. October 2019 [internet publication].Full text

32. World Health Organization. Smallpox. 2022 [internet publication].Full text

33. Centers for Disease Control and Prevention. Smallpox: prevention and treatment. August 2022 [internet publication].Full text

34. Grosenbach DW, Honeychurch K, Rose EA, et al. Oral tecovirimat for the treatment of smallpox. N Engl J Med. 2018 Jul 5;379(1):44-53.Full text  Abstract

35. Chan-Tack K, Harrington P, Bensman T, et al. Benefit-risk assessment for brincidofovir for the treatment of smallpox: US Food and Drug Administration's evaluation. Antiviral Res. 2021 Nov;195:105182. Abstract

36. ClinicalTrials.gov. A trial to assess the safety, tolerability, and pharmacokinetics of the anti-orthopoxvirus compound tecovirimat (SIGA246-008). November 2017 [internet publication].Full text

37. Hopkins RJ, Lane JM. Clinical efficacy of intramuscular vaccinia immune globulin: a literature review. Clin Infect Dis. 2004 Sep 15;39(6):819-26.Full text  Abstract

38. Mazurkov OY, Kabanov AS, Shishkina LN, et al. New effective chemically synthesized anti-smallpox compound NIOCH-14. J Gen Virol. 2016 May;97(5):1229-39.Full text  Abstract

39. Delaune D, Iseni F. Drug development against smallpox: present and future. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e01683-19.Full text  Abstract

40. Lane JM. The current and future landscape of smallpox vaccines. J Glob Security. 2019 Feb 14;1(1).Full text

41. World Health Organization. WHO advisory committee on variola virus research: report of the twenty-third meeting, virtual meeting, 3-4 November 2021. May 2022 [internet publication].Full text

42. Kunasekaran MP, Chen X, Costantino V, et al. Evidence for residual immunity to smallpox after vaccination and implications for re-emergence. Mil Med. 2019 Dec 1;184(11-12):e668-79.Full text  Abstract

43. Regan TD, Norton SA. The scarring mechanism of smallpox. J Am Acad Dermatol. 2004 Apr;50(4):591-4. Abstract

44. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Full text  Abstract

45. Hu G, Wang MJ, Miller MJ, et al. Ocular vaccinia following exposure to a smallpox vaccinee. Am J Ophthalmol. 2004 Mar;137(3):554-6. Abstract

46. Lane JM, Summer L. Smallpox as a weapon for bioterrorism. In: Fong IW, Alibek K, eds. Bioterrorism and infectious agents: a new dilemma for the 21st century. New York, NY: Springer; 2009:147-67.Full text